Phase I/II, Study of Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330) + Sorafenib in Acute Myeloid Leukemia
Clinical trial NCT02530476 · COMPLETED
Trial details
- NCT number
- NCT02530476
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-08
- Primary completion
- 2019-04-08
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.